Greg Kupp is the President of Pace® Life Sciences for Pace®, which includes the operations in Oakdale, Minnesota, and San German, Puerto Rico. He joined Pace® in 2006 and has more than 25 years of managerial and business development experience in the life science industry including executive level management, information technology and laboratory operations.
For the past ten years, Mr. Kupp has been responsible for the strategic growth, operational leadership and management of the growing Pace® Life Sciences business. He is responsible for overall operations and administration of the Pace® Life Sciences laboratories; oversight of all regulatory and compliance standards for laboratories; procurement of required personnel and equipment; and long-range, capital and strategic planning for Pace® Life Sciences business.
Under his management, Pace® has developed into a key supplier of analytical and microbiology services within the Life Sciences industry. During his tenure at Pace®, Mr. Kupp was instrumental in developing the overall business models and the quality system, as well as the laboratory information management system (LIMs) employed within the laboratory. Under his leadership the Life Sciences laboratory operations have been approved as a supplier by many of the world’s top health care companies. In addition, the laboratory sites have experienced numerous successful regulatory audits. His efforts to drive the development of a client-focused work culture – where the emphasis is focused on understanding customer requirements and delivering a timely, cost-effective and innovative solution to each customer – has played a critical role in the significant growth of Pace® in the Life Sciences business over the past several years.
Mr. Kupp holds a B.S. Degree in Biology from Misericordia University and an M.S. degree in Quality Assurance/Regulatory Affairs from Temple University.